par Lauren Dubinsky
, Senior Reporter | March 02, 2020
From the March 2020 issue of HealthCare Business News magazine
“If you’re going to create a great device, you also have to create a methodology by which it fits into the way we practice medicine,” said Martin.
The market at large
Due to the increasing prevalence of diabetes and obesity as well as the growing elderly population, cardiovascular disease is on the rise, and the need for procedures such as transcatheter aortic valve replacement (TAVR), tricuspid valve procedures and mitral valve procedures is increasing. The cardiac ultrasound market is expected to grow from $1.45 billion in 2016 to $1.72 billion in 2023, according to a Market Watch report published in April 2019.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
In August, the FDA approved an expanded indication for TAVR to include patients with severe aortic valve stenosis at low surgical risk. Previously, only patients at high surgical risk were candidates for this procedure.
“There are a lot of hospitals now opening structural heart services, 3D transesophageal echo is now standard of care in these cases, and older equipment won’t necessarily support that new technology,” said Canon’s McElroy.Back to HCB News